| Product NDC: | 11980-801 |
| Proprietary Name: | OCUFEN |
| Non Proprietary Name: | flurbiprofen sodium |
| Active Ingredient(s): | .3 mg/mL & nbsp; flurbiprofen sodium |
| Administration Route(s): | OPHTHALMIC |
| Dosage Form(s): | SOLUTION/ DROPS |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11980-801 |
| Labeler Name: | Allergan, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019404 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19870101 |
| Package NDC: | 11980-801-03 |
| Package Description: | 1 BOTTLE, DROPPER in 1 CARTON (11980-801-03) > 2.5 mL in 1 BOTTLE, DROPPER |
| NDC Code | 11980-801-03 |
| Proprietary Name | OCUFEN |
| Package Description | 1 BOTTLE, DROPPER in 1 CARTON (11980-801-03) > 2.5 mL in 1 BOTTLE, DROPPER |
| Product NDC | 11980-801 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | flurbiprofen sodium |
| Dosage Form Name | SOLUTION/ DROPS |
| Route Name | OPHTHALMIC |
| Start Marketing Date | 19870101 |
| Marketing Category Name | NDA |
| Labeler Name | Allergan, Inc. |
| Substance Name | FLURBIPROFEN SODIUM |
| Strength Number | .3 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |